(Q47309800)

13 January 2018

title

Perioperative low molecular weight heparin for infrageniculate bypass (English)

1 reference

13 January 2018

author name string

McMillan WD

1

1 reference

13 January 2018

McCarthy WJ

2

1 reference

13 January 2018

Lin SJ

3

1 reference

13 January 2018

Matsumura JS

4

1 reference

13 January 2018

Pearce WH

5

1 reference

13 January 2018

Yao JS

6

1 reference

13 January 2018

publication date

1 May 1997

1 reference

13 January 2018

Journal of Vascular Surgery

published in

1 reference

13 January 2018

volume

25

1 reference

13 January 2018

issue

5

1 reference

13 January 2018

page(s)

796-801; discussion 801-2

1 reference

13 January 2018

A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2897%2970208-8

7 January 2021

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2897%2970208-8

7 January 2021

Clinical assessment of low molecular weight heparin effects in peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2897%2970208-8

7 January 2021

Low-molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2897%2970208-8

7 January 2021

Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2897%2970208-8

7 January 2021

Pharmacokinetic Studies of Standard Unfractionated Heparin, and Low Molecular Weight Heparins in the Rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2897%2970208-8

7 January 2021

Comparative pharmacokinetics of a low molecular weight heparin (PK 10 169) and unfractionated heparin after intravenous and subcutaneous administration

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2897%2970208-8

7 January 2021

Secondary femoropopliteal reconstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2897%2970208-8

7 January 2021

The efficacy of dextran 40 in preventing early postoperative thrombosis following difficult lower extremity bypass

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2897%2970208-8

7 January 2021

Technical defects as a cause of early graft failure after femorodistal bypass

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2897%2970208-8

7 January 2021

Optimal Therapeutic Level of Heparin Therapy in Patients With Venous Thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2897%2970208-8

7 January 2021

Random control trial of a short course of aspirin and dipyridamole (Persantin) for femorodistal grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2897%2970208-8

7 January 2021

A prospective randomized trial of aspirin in femoral popliteal and tibial bypass grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2897%2970208-8

7 January 2021

Avoiding early failure of tibial prosthetic bypass grafts.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2897%2970208-8

7 January 2021

A decade of oral anticoagulant treatment to maintain autologous vein grafts for femoropopliteal atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2897%2970208-8

7 January 2021

Influence of anticoagulant treatment in preventing graft occlusion following saphenous vein bypass for femoropopliteal occlusive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2897%2970208-8

7 January 2021

Influence of coumarin treatment on patency and limb salvage after peripheral arterial reconstructive surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2897%2970208-8

7 January 2021

Seven-year experience with polytetrafluoroethylene as above-knee femoropopliteal bypass graft. Is is worthwhile to preserve the autologous saphenous vein?

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2897%2970208-8

7 January 2021

10.1016/S0741-5214(97)70208-8

Identifiers

DOI

1 reference

13 January 2018

1 reference

13 January 2018